French research institute initiates combination study of clevudine and viread for HBV

Bukwang Pharm says the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), with the support of Pharmasset, Inc. and Gilead Sciences, Inc. has initiated the first head-to-head study of clevudine and Viread (tenofovir disoproxil fumarate) administered separately, versus their combination, for the treatment of chronic hepatitis B virus (HBV) infection in non-cirrhotic patients....